{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:11:29Z","timestamp":1789827089668,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007028"],"award-info":[{"award-number":["T32DK007028"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chen Institute MGH Research Scholars Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hip fracture is a global public health concern, with over 10 million cases worldwide in 2019. Post-hip fracture outcomes, including mortality, vary by type 2 diabetes (T2D) co-diagnosis and patient demographics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine post-hip fracture outcomes and identify factors modifying mortality differences in a racially and ethnically diverse population of older United States (US) adults with T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study using Medicare fee-for-service data from 2014 to 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Men and women aged\u2009&gt;\u200965\u00a0years, with T2D diagnosis who had experienced a non-traumatic hip fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measure(s)<\/jats:title>\n                    <jats:p>We evaluated associations between race and ethnicity and one-year mortality, dual energy x-ray absorptiometry (DXA) testing, osteoporosis treatment, and incident destitution post-hip fracture using multivariable Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>Among 159,699 older adults with T2D, one-year post-hip fracture mortality was 30.4%. In age- and sex-adjusted models, mortality was higher in Black individuals (HR 1.26 [95% CI, 1.22\u20131.31) and lower in Asian and Hispanic individuals (HR 0.78 [95% CI, 0.73\u20130.83] and 0.91 [95% CI,0.86\u20130.96], respectively) compared with White individuals. Elevated mortality in Black individuals persisted across subgroups stratified by sex, age, region, BMI, and frailty, but not among those with advanced chronic kidney disease (CKD stages 4\u20135; HR 1.01 [0.93\u20131.09]) or low socioeconomic status (SES; Medicaid eligibility; HR 1.00 [0.88\u20131.14]). Models adjusting for important demographic and clinical covariates mitigated mortality differences between Black and White individuals. DXA testing and osteoporosis treatment initiation rates were low overall (7.3% and 5.6%, respectively). Black individuals had lower DXA testing (HR 0.51 [0.45\u20130.56]) and treatment (HR 0.58 [0.51\u20130.65]) rates, and higher incident destitution (HR 1.41 [1.29\u20131.55]) than White individuals in all models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall mortality was high and guideline-concordant care was low in the first year post-hip fracture in Medicare-insured older adults with T2D. Furthermore, racial and ethnic differences in post-hip fracture mortality and management exist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-026-10516-1","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:31:43Z","timestamp":1781537503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Observational Study of Post-hip Fracture Outcomes in Older Adults with Type 2 Diabetes"],"prefix":"10.1007","author":[{"given":"Keity M.","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipi A.","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri-Ann M.","family":"Burnett-Bowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Cromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janinne","family":"Ortega-Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline F.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Patorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-0839","authenticated-orcid":false,"given":"Elaine W.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"10516_CR1","doi-asserted-by":"crossref","unstructured":"Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017\u20132018. 2021, National Center for Health Statistics.","DOI":"10.15620\/cdc:103477"},{"key":"10516_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2474-12-105","volume":"12","author":"J Panula","year":"2011","unstructured":"Panula J, et al. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord, 2011;12:105.","journal-title":"BMC Musculoskelet Disord"},{"key":"10516_CR3","unstructured":"Foundation IO. Infographics. [cited 2025 June 24]; Available from: https:\/\/www.osteoporosis.foundation\/educational-hub\/material\/infographics."},{"issue":"8","key":"10516_CR4","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jgs.16455","volume":"68","author":"NC Wright","year":"2020","unstructured":"Wright NC, et al. Racial disparities exist in outcomes after major fragility fractures. J Am Geriatr Soc, 2020;68(8):1803\u20131810.","journal-title":"J Am Geriatr Soc"},{"key":"10516_CR5","doi-asserted-by":"crossref","unstructured":"Force USPST. Screening for osteoporosis to prevent fractures: U.S. Preventive Services Task Force recommendation statement. JAMA. 2018;319(24):2521\u20132531.","DOI":"10.1001\/jama.2018.7498"},{"key":"10516_CR6","doi-asserted-by":"crossref","unstructured":"French S, Schmajuk G. Quality measures and quality improvement initiatives in osteoporosis\u2014an update. Curr Osteoporos Rep. 2019;17.","DOI":"10.1007\/s11914-019-00547-5"},{"issue":"3","key":"10516_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","volume":"29","author":"EM Lewiecki","year":"2018","unstructured":"Lewiecki EM, et al. Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int. 2018;29(3):717\u2013722.","journal-title":"Osteoporos Int"},{"issue":"8","key":"10516_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s11606-021-06938-8","volume":"37","author":"SJ Cromer","year":"2022","unstructured":"Cromer SJ, et al. Secular trends in the pharmacologic treatment of osteoporosis and malignancy-related bone disease from 2009 to 2020. J Gen Intern Med. 2022;37(8):1917\u20131924.","journal-title":"J Gen Intern Med"},{"key":"10516_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.maturitas.2021.10.010","volume":"156","author":"KN Ruiz-Esteves","year":"2022","unstructured":"Ruiz-Esteves KN. et al. Disparities in osteoporosis care among postmenopausal women in the United States. Maturitas. 2022;156:25\u201329.","journal-title":"Maturitas"},{"issue":"4","key":"10516_CR10","first-page":"265","volume":"38","author":"I Hamrick","year":"2006","unstructured":"Hamrick, I., et al., Health care disparities in postmenopausal women referred for DXA screening. Fam Med, 2006. 38(4): p. 265\u20139.","journal-title":"Fam Med"},{"issue":"10","key":"10516_CR11","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/jbmr.4417","volume":"36","author":"SE Noel","year":"2021","unstructured":"Noel SE, Santos MP, Wright NC. Racial and ethnic disparities in bone health and outcomes in the United States. J Bone Miner Res. 2021;36(10):1881\u20131905.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10516_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1089\/jwh.2012.3812","volume":"21","author":"I Hamrick","year":"2012","unstructured":"Hamrick I, et al. Osteoporosis healthcare disparities in postmenopausal women. J Womens Health (Larchmt). 2012;21(12):1232\u20136.","journal-title":"J Womens Health (Larchmt)"},{"key":"10516_CR13","unstructured":"NIDDK. Diabetes Statistics. [cited 2025; Available from: https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/diabetes-statistics."},{"key":"10516_CR14","unstructured":"ADA. Statistics About Diabetes. [cited 2025 June 21]; Available from: https:\/\/diabetes.org\/about-diabetes\/statistics\/about-diabetes."},{"issue":"7","key":"10516_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2337\/db16-0063","volume":"65","author":"DE Sellmeyer","year":"2016","unstructured":"Sellmeyer DE, et al. Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes. Diabetes. 2016;65(7):1757\u201366.","journal-title":"Diabetes"},{"issue":"11","key":"10516_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","volume":"17","author":"S Khosla","year":"2021","unstructured":"Khosla S, et al. Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17(11):685\u2013697.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10516_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s11914-021-00715-6","volume":"19","author":"V Van Hulten","year":"2021","unstructured":"Van Hulten V, et al. Fracture patterns in type 1 and type 2 diabetes mellitus: a narrative review of recent literature. Curr Osteoporos Rep. 2021;19(6):644\u2013655.","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"10516_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.25106","volume":"7","author":"M Zoulakis","year":"2024","unstructured":"Zoulakis M, et al. Type 2 diabetes and fracture risk in older women. JAMA Netw Open. 2024;7(8):e2425106.","journal-title":"JAMA Netw Open"},{"key":"10516_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115457","volume":"137","author":"T Vilaca","year":"2020","unstructured":"Vilaca T, et al. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone. 2020;137:115457.","journal-title":"Bone"},{"issue":"21","key":"10516_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2011.715","volume":"305","author":"AV Schwartz","year":"2011","unstructured":"Schwartz AV, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184\u201392.","journal-title":"JAMA"},{"key":"10516_CR21","doi-asserted-by":"crossref","unstructured":"Lee TC, et al. Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan. BMJ Open Diabetes Res Care. 2020;8(1).","DOI":"10.1136\/bmjdrc-2019-000843"},{"key":"10516_CR22","doi-asserted-by":"crossref","unstructured":"Moayeri A, et al. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13(null):455\u2013468.","DOI":"10.2147\/TCRM.S131945"},{"issue":"12","key":"10516_CR23","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00198-019-05122-3","volume":"30","author":"C Tebe","year":"2019","unstructured":"Tebe C, et al. The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis. Osteoporos Int. 2019;30(12):2407\u20132415.","journal-title":"Osteoporos Int"},{"key":"10516_CR24","unstructured":"Office of Inspector General. A resource guide for using Medicare's enrollment race and ethnicity data. US Department of Health and Human Services. 2023."},{"key":"10516_CR25","doi-asserted-by":"crossref","unstructured":"Reitsma MB, McGuire TG, Rose S. Algorithms to improve fairness in medicare risk adjustment. medRxiv. 2025.","DOI":"10.1101\/2025.01.25.25321057"},{"issue":"1","key":"10516_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MLR.0000000000001216","volume":"58","author":"OF Jarr\u00edn","year":"2020","unstructured":"Jarr\u00edn OF, et al. Validity of race and ethnicity codes in medicare administrative data compared with gold-standard self-reported race collected during routine home health care visits. Med Care. 2020;58(1):e1\u2013e8.","journal-title":"Med Care"},{"issue":"12","key":"10516_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314345","volume":"19","author":"LR Jackson 2nd","year":"2024","unstructured":"Jackson LR 2nd, et al. Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation. PLoS One. 2024;19(12):e0314345.","journal-title":"PLoS One"},{"key":"10516_CR28","doi-asserted-by":"crossref","unstructured":"Poghosyan L, et al. Racial disparities in hospitalization and neighborhood deprivation among Medicare beneficiaries. Health Aff Sch. 2025;3(2):qxaf010.","DOI":"10.1093\/haschl\/qxaf010"},{"issue":"5","key":"10516_CR29","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1007\/s40615-022-01415-2","volume":"10","author":"H Poghosyan","year":"2023","unstructured":"Poghosyan H, et al. Racial and ethnic variation in COVID-19 vaccination uptake among Medicare beneficiaries with cancer history. J Racial Ethn Health Disparities. 2023;10(5):2354\u20132362.","journal-title":"J Racial Ethn Health Disparities"},{"key":"10516_CR30","unstructured":"Assurance NCfQ. HEDIS Measure Description. 2025."},{"key":"10516_CR31","doi-asserted-by":"crossref","unstructured":"Ganz DA, et al. Validation of a rule-based ICD-10-CM algorithm to detect fall injuries in Medicare data. J Gerontol A Biol Sci Med Sci. 2024;79(7).","DOI":"10.1093\/gerona\/glae096"},{"issue":"1","key":"10516_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40621-015-0066-z","volume":"3","author":"SB Kim","year":"2016","unstructured":"Kim SB, et al. Development of an algorithm to identify fall-related injuries and costs in Medicare data. Inj Epidemiol. 2016;3(1):1.","journal-title":"Inj Epidemiol"},{"issue":"8","key":"10516_CR33","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","volume":"74","author":"DH Kim","year":"2019","unstructured":"Kim DH, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. J Gerontol A Biol Sci Med Sci. 2019;74(8):1271\u20131276.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"10516_CR34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","volume":"64","author":"JJ Gagne","year":"2011","unstructured":"Gagne JJ, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749\u201359.","journal-title":"J Clin Epidemiol"},{"issue":"446","key":"10516_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"10516_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/gerona\/63.8.860","volume":"63","author":"JE Graham","year":"2008","unstructured":"Graham JE, et al. Race\/ethnicity and outcomes following inpatient rehabilitation for hip fracture. J Gerontol A Biol Sci Med Sci. 2008;63(8):860\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10516_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0733464814541325","volume":"35","author":"MP Cary Jr","year":"2016","unstructured":"Cary MP Jr., et al. Inpatient rehabilitation outcomes in a national sample of Medicare beneficiaries with hip fracture. J Appl Gerontol. 2016;35(1):62\u201383.","journal-title":"J Appl Gerontol"},{"issue":"8","key":"10516_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2105\/AJPH.82.8.1147","volume":"82","author":"SJ Jacobsen","year":"1992","unstructured":"Jacobsen SJ, et al. Race and sex differences in mortality following fracture of the hip. Am J Public Health. 1992;82(8):1147\u201350.","journal-title":"Am J Public Health"},{"issue":"10","key":"10516_CR39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2106\/JBJS.15.00676","volume":"98","author":"CJ Dy","year":"2016","unstructured":"Dy CJ, et al. Racial and socioeconomic disparities in hip fracture care. J Bone Joint Surg Am. 2016;98(10):858\u201365.","journal-title":"J Bone Joint Surg Am"},{"key":"10516_CR40","unstructured":"Centers for Disease Control and Prevention. Data & research on diabetes. U.S. Department of Health & Human Services. 2023."},{"issue":"4","key":"10516_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020312","volume":"8","author":"L Robertson","year":"2018","unstructured":"Robertson L, et al. Hip fracture incidence and mortality in chronic kidney disease: the GLOMMS-II record linkage cohort study. BMJ Open. 2018;8(4):e020312.","journal-title":"BMJ Open"},{"issue":"10","key":"10516_CR42","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/jbmr.2862","volume":"31","author":"SM Kim","year":"2016","unstructured":"Kim SM, et al. Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res. 2016;31(10):1803\u20131809.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10516_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/intqhc\/mzp046","volume":"21","author":"AP Barone","year":"2009","unstructured":"Barone AP, et al. Effects of socioeconomic position on 30-day mortality and wait for surgery after hip fracture. Int J Qual Health Care. 2009;21(6):379\u201386.","journal-title":"Int J Qual Health Care"},{"issue":"10407","key":"10516_CR44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(23)01088-7","volume":"402","author":"GUHD Collaborators","year":"2023","unstructured":"Collaborators GUHD. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities. Lancet. 2023;402(10407):1065\u20131082.","journal-title":"Lancet"},{"issue":"10077","key":"10516_CR45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey ZD, et al. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453\u20131463.","journal-title":"Lancet"},{"issue":"1","key":"10516_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.54701","volume":"9","author":"ID Spears","year":"2026","unstructured":"Spears ID, et al. Cumulative lifespan stress, inflammation, and racial disparities in mortality between Black and White adults. JAMA Netw Open. 2026;9(1):e2554701.","journal-title":"JAMA Netw Open"},{"issue":"134","key":"10516_CR47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1183\/09059180.00000814","volume":"23","author":"RP Young","year":"2014","unstructured":"Young RP, Hopkins RJ. A review of the Hispanic paradox: time to spill the beans? Eur Respir Rev. 2014;23(134):439\u201349.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10516_CR48","first-page":"496","volume":"11","author":"L Franzini","year":"2001","unstructured":"Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis. 2001;11(3):496\u2013518.","journal-title":"Ethn Dis"},{"key":"10516_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116216","volume":"154","author":"TW Tai","year":"2022","unstructured":"Tai TW, et al. Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study. Bone. 2022;154:116216.","journal-title":"Bone"},{"issue":"18","key":"10516_CR50","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799\u2013809.","journal-title":"N Engl J Med"},{"issue":"9","key":"10516_CR51","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1007\/s00198-016-3608-5","volume":"27","author":"K Thorne","year":"2016","unstructured":"Thorne K, et al. The impact of social deprivation on mortality following hip fracture in England and Wales: a record linkage study. Osteoporos Int. 2016;27(9):2727\u20132737.","journal-title":"Osteoporos Int"},{"issue":"2","key":"10516_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00198-018-4768-2","volume":"30","author":"T Holmberg","year":"2019","unstructured":"Holmberg T, et al. Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study. Osteoporos Int. 2019;30(2):343\u2013353.","journal-title":"Osteoporos Int"},{"key":"10516_CR53","unstructured":"KF, F. Medicaid Income Eligibility Limits for Adults as a Percent of the Federal Poverty Level. 2024; Available from: https:\/\/www.kff.org\/affordable-care-act\/state-indicator\/medicaid-income-eligibility-limits-for-adults-as-a-percent-of-the-federal-poverty-level\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D."},{"key":"10516_CR54","unstructured":"Evaluation, A.S.f.P.a. 2025 Poverty Guidelines: 48 Contiguous States (Detailed Guidelines). [cited 2025 June]; Available from: https:\/\/www.aspe.hhs.gov\/sites\/default\/files\/documents\/dd73d4f00d8a819d10b2fdb70d254f7b\/detailed-guidelines-2025.pdf."},{"issue":"5","key":"10516_CR55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jbmr\/zjae048","volume":"39","author":"SM Burnett-Bowie","year":"2024","unstructured":"Burnett-Bowie SM, et al. The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report. J Bone Miner Res. 2024;39(5):517\u2013530.","journal-title":"J Bone Miner Res."},{"issue":"11","key":"10516_CR56","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/jbmr.1684","volume":"27","author":"NC Wright","year":"2012","unstructured":"Wright NC, et al. Recent trends in hip fracture rates by race\/ethnicity among older US adults. J Bone Miner Res. 2012;27(11):2325\u201332.","journal-title":"J Bone Miner Res"},{"key":"10516_CR57","unstructured":"Hansen D, Pelizzari P, Pyenson B. Medicare cost of osteoporotic fractures: 2021 updated report. 2021 [cited 2025 June]; Available from: https:\/\/www.milliman.com\/en\/insight\/medicare-cost-of-osteoporotic-fractures-2021-updated-report."},{"issue":"9","key":"10516_CR58","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11606-007-0217-1","volume":"22","author":"JM Neuner","year":"2007","unstructured":"Neuner JM, et al. Racial and socioeconomic disparities in bone density testing before and after hip fracture. J Gen Intern Med. 2007;22(9):1239\u201345.","journal-title":"J Gen Intern Med"},{"key":"10516_CR59","doi-asserted-by":"crossref","unstructured":"Rudisill KE, et al. Disparities in dual-energy X-ray absorptiometry scan utilization across race\/ethnic groups before and after hip fractures. J Am Acad Orthop Surg Glob Res Rev. 2024;8(9).","DOI":"10.5435\/JAAOSGlobal-D-24-00052"},{"issue":"11","key":"10516_CR60","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jgs.12507","volume":"61","author":"SK Liu","year":"2013","unstructured":"Liu SK, et al. Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc. 2013;61(11):1855\u201362.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10516_CR61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers C, et al. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians. Ann Intern Med. 2023;176(2):182\u2013195.","journal-title":"Ann Intern Med"},{"issue":"8","key":"10516_CR62","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1359\/jbmr.080323","volume":"23","author":"LJ Melton 3rd","year":"2008","unstructured":"Melton LJ 3rd, et al. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008;23(8):1334\u201342.","journal-title":"J Bone Miner Res"},{"key":"10516_CR63","unstructured":"Committee ADAPP. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142024. Diabetes Care. 2023;47(Supplement_1):S52\u2013S76."},{"key":"10516_CR64","doi-asserted-by":"crossref","unstructured":"Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med. 2023;176(2):224\u2013238.","DOI":"10.7326\/M22-1034"},{"issue":"7","key":"10516_CR65","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1007\/s12325-021-01792-w","volume":"38","author":"S Ramachandran","year":"2021","unstructured":"Ramachandran S, et al. Gender disparities in osteoporosis screening and management among older adults. Adv Ther. 2021;38(7):3872\u20133887.","journal-title":"Adv Ther"},{"issue":"2","key":"10516_CR66","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1053\/j.ajkd.2013.01.019","volume":"62","author":"SF Derose","year":"2013","unstructured":"Derose SF, et al. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis. 2013;62(2):236\u201344.","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10516-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:02:34Z","timestamp":1781542954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10516-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":66,"alternative-id":["10516"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10516-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Patorno is the primary investigator of a research grant to Brigham and Women\u2019s Hospital from Boehringer Ingelheim, not related to the topic of this work. Dr. Yu is a principal investigator of a research grant to the Massachusetts General Hospital from Amgen Inc, not related to the topic of this work. Dr. Yu reports royalties from UpToDate and consulting for AbbVie, not related to the topic of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Approval for this study was obtained by the Mass General Brigham institutional review board (protocol #2024P000387) and a data use agreement was completed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate Declarations"}},{"value":"The remaining authors declare no affiliations or financial interests that conflict with the material presented in this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}